Recombinant protein · Agonist · developed by Organon and Co
hCG bolus injection is a subcutaneous dose of human chorionic gonadotropin given to induce final oocyte maturation once follicles reach a set size during ovarian stimulation.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00702338 | N/A | Pregnancy | Completed | OGN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
NeonatesPregnancy
Updated Oct 25, 2026. Something wrong or missing? Report it on the OGN page.
See OGN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
OGN catalysts and pipeline →